IP Library Granted Patent US 8,956,834
Granted Patent B2
US 8,956,834 · App. 12/826,592 · Granted Feb 17, 2015

Acyl-ACP thioesterase genes and uses therefor

Inventors: Paul Gordon Roessler (San Diego, CA); Gena Roy (San Diego, CA)
Assignee: Synthetic Genomics, Inc.
C12N9/16C12N15/8247C12P7/6409C12P7/6436C12P7/6463
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,956,834
App. No.
12/826,592
Granted
Feb 17, 2015
Kind
B2
Abstract

The present invention provides novel genes encoding Class II acyl-ACP thioesterases and variants thereof that are active on C8, C10, C12, C14, C16, and C18 acyl-ACP substrates. The thioesterases can be introduced into transgenic organisms, including microorganisms and photosynthetic organisms, for producing fatty acids and fatty acid products.

Claims (29)

1. A mutant acyl-ACP thioesterase gene encoding a variant of a C8-preferring acyl-ACP thioesterase comprising a mutation that changes the amino acid at the amino acid position corresponding to amino acid position 174 of SEQ ID NO:29 to valine or isoleucine;

wherein the variant acyl-ACP thioesterase has a higher activity on a C8 substrate than the native acyl-ACP thioesterase while retaining the C8 acyl chain length substrate preference of the native thioesterase, and further wherein said variant comprises an amino acid sequence having at least 95% identity to amino acids 65 to 355 of SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

2. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the mutation is M174I.

3. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the thioesterase gene is selected from the group consisting of SEQ ID NO:39, SEQ ID NO:42, or SEQ ID NO:44.

4. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the gene encodes an acyl-ACP thioesterase that comprises an amino acid sequence having at least 95% identity to SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

5. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the gene encodes an acyl-ACP thioesterase than comprises an amino acid sequence having at least 99% identity to amino acids 65 to 355 of SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

6. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the gene encodes an acyl-ACP thioesterase that comprises an amino acid sequence having at least 99% identity to SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

7. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the variant comprises an amino acid sequence having at least 95% identity to amino acids 34 to 355 of SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

8. The mutant acyl-ACP thioesterase gene of claim 7 , wherein the mutation is M174I.

9. The mutant acyl-ACP thioesterase gene of claim 7 , wherein the variant comprises amino acids 34 to 355 of SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

10. The mutant acyl-ACP thioesterase gene of claim 1 , wherein the variant comprises SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

11. A mutant acyl-ACP thioesterase gene encoding a variant of a C8-preferring acyl-ACP thioesterase comprising a mutation that changes the amino acid at the amino acid position corresponding to amino acid position 174 of SEQ ID NO:29 to cysteine, phenylalanine, valine, leucine, or isoleucine;

wherein the variant thioesterase comprises isoleucine at the amino acid position corresponding to amino acid position 103 of SEQ ID NO:29;

wherein the variant acyl-ACP thioesterase has a higher activity on a C8 substrate than the native acyl-ACP thioesterase while retaining the C8 acyl chain length substrate preference of the native thioesterase, and further wherein said variant comprises an amino acid sequence having at least 95% identity to amino acids 65 to 355 of SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

12. The mutant acyl-ACP thioesterase gene of claim 11 , wherein the variant comprises an amino acid sequence having at least 95% identity to amino acids 34 to 355 of SEQ ID NO:40, SEQ ID NO:43, or SEQ ID NO:45.

13. The mutant acyl-ACP thioesterase gene of claim 12 , wherein the mutation is M174I.

14. The mutant acyl-ACP thioesterase gene of claim 11 , wherein the variant comprises amino acids 34 to 355 of SEQ ID NO:40 or SEQ ID NO:45.

15. A method of making a fatty acid product, comprising: culturing a microorganism transformed with a mutant acyl-ACP thioesterase gene of claim 1 and isolating a fatty acid product from the microorganism or culture medium, wherein at least 70% of the fatty acid products isolated from the cells and/or culture media are fatty acid products of a C8 chain length.

16. The method of claim 15 , wherein the fatty acid products are free fatty acids, fatty alcohols, fatty aldehydes, or fatty esters.

17. The method of claim 16 , wherein the fatty acid products are free fatty acids.

18. The method of claim 15 , wherein the fatty acid product is isolated from the culture medium.

19. The method of claim 15 , wherein the sequence encoding the acyl-ACP thioesterase is codon-optimized for expression in the microorganism.

20. The method of claim 15 , wherein the microorganism is a photosynthetic microorganism.

21. The method of claim 20 , wherein the microorganism is cultured phototrophically.

22. The method of claim 20 , wherein the microorganism is cultured mixotrophically.

23. The method of claim 15 , wherein the fatty acid product is isolated from whole culture or cells.

24. The method of claim 20 , wherein the photosynthetic organism is an Achnanthes, Amphiprora, Amphora, Ankistrodesmus, Asteromonas, Boekelovia, Borodinella, Botryococcus, Bracteococcus, Chaetoceros, Carteria, Chlamydomonas, Chlorococcum, Chlorogonium, Chlorella, Chroomonas, Chrysosphaera, Cricosphaera, Crypthecodinium, Cryptomonas, Cyclotella, Dunaliella, Ellipsoidon, Emiliania, Eremosphaera, Ernodesmius, Euglena, Franceia, Fragilaria, Gloeothamnion, Haematococcus, Halocafeteria, Hymenomonas, Isochrysis, Lepocinclis, Micractinium, Monoraphidium, Nannochloris, Nannochloropsis, Navicula, Neochloris, Nephrochloris, Nephroselmis, Nitzschia, Ochromonas, Oedogonium, Oocystis, Ostreococcus, Pavlova, Parachlorella, Pascheria, Phaeodactylum, Phagus, Platymonas, Pleurochrysis, Pleurococcus, Prototheca, Pseudochlorella, Pyramimonas, Pyrobotrys, Scenedesmus, Schizochytrium, Skeletonema, Spyrogyra, Stichococcus, Tetraselmis, Thalassiosira, Viridiella , or Volvox species.

25. The method of claim 20 , wherein the photosynthetic organism is a cyanobacterium.

26. The method of claim 25 , wherein the photosynthetic organism is an Agmenellum, Anabaena, Anabaenopsis, Anacystis, Aphanizomenon, Arthrospira, Asterocapsa, Borzia, Calothrix, Chamaesiphon, Chlorogloeopsis, Chroococcidiopsis, Chroococcus, Crinalium, Cyanobacterium, Cyanobium, Cyanocystis, Cyanospira, Cyanothece, Cylindrospermopsis, Cylindrospermum, Dactylococcopsis, Dermocarpella, Fischerella, Fremyella, Geitleria, Geitlerinema, Gloeobacter, Gloeocapsa, Gloeothece, Halospirulina, Iyengariella, Leptolyngbya, Limnothrix, Lyngbya, Microcoleus, Microcystis, Myxosarcina, Nodularia, Nostoc, Nostochopsis, Oscillatoria, Phormidium, Planktothrix, Pleurocapsa, Prochlorococcus, Prochloron, Prochlorothrix, Pseudanabaena, Rivularia, Schizothrix, Scytonema, Spirulina, Stanieria, Starria, Stigonema, Symploca, Synechococcus, Synechocystis, Tolypothrix, Trichodesmium, Tychonema , or Xenococcus species.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
SECURITY INTEREST Recorded Mar 20, 2019
From: SYNTHETIC GENOMICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 048655/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2010
From: ROESSLER, PAUL G.; ROY, GENA
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 024627/0929 →
Continuity (3)
Provisional Application 61221500 · Jun 29, 2009
Provisional Application 61223328 · Jul 6, 2009
Related Publication 20110020883A1 · Jan 27, 2011